These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7875791)

  • 1. Intravenous immunoglobulin therapy for hyperbilirubinemia caused by Rhesus hemolytic disease.
    Merchant RH; Pradeep S
    Indian Pediatr; 1994 Oct; 31(10):1269-71. PubMed ID: 7875791
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
    Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
    J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of phototherapy on the hyperbilirubinemia of rhesus incompatibility.
    Shennan AT
    Pediatrics; 1974 Oct; 54(4):417-22. PubMed ID: 4213433
    [No Abstract]   [Full Text] [Related]  

  • 5. [Personal experience with the use of light in paraphysiological neonatal hyperbilirubinemia and hemolytic disease of the newborn due to Rh and ABO factors].
    Salvioli GP; Dallacasa P
    Minerva Pediatr; 1972 Feb; 24(3):113-23. PubMed ID: 4622393
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin in neonatal rhesus hemolytic disease.
    Greenough A
    Indian Pediatr; 2008 Aug; 45(8):649-50. PubMed ID: 18723906
    [No Abstract]   [Full Text] [Related]  

  • 7. [Investigations of conjugated bilirubinoids for the diagnosis of rhesus-incompatibility and clarification of fetal bilirubin metabolism].
    Kopecky P
    Z Geburtshilfe Perinatol; 1974 Oct; 178(5):349-59. PubMed ID: 4217504
    [No Abstract]   [Full Text] [Related]  

  • 8. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of single versus double volume exchange transfusion in newborn infants with AB0 hemolytic disease.
    Amato M; Blumberg A; Hermann U; Zurbrügg R
    Helv Paediatr Acta; 1988 Nov; 43(3):177-86. PubMed ID: 3220789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of hemolysis.
    Zipursky A
    Mead Johnson Symp Perinat Dev Med; 1982; (19):17-24. PubMed ID: 6821465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of mixed hyperbilirubinemia in neonatal hemolytic disease caused by Rh materno-fetal isoimmunization].
    Centa A
    Pathologica; 1967; 59(879):513-8. PubMed ID: 5634190
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal jaundice: physiologic variation or pathologic process.
    Reiser DJ
    Crit Care Nurs Clin North Am; 2004 Jun; 16(2):257-69. PubMed ID: 15145371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic significance of the determination of bilirubin fractions in the hemolytic disease of newborns].
    Hodr R; Strnad L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1967; 10(1):21-7. PubMed ID: 5239111
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of Bilirubin According to the Results of the Direct Antiglobulin Test and Its Impact in Hemolytic Disease of the Newborn.
    Shin KH; Lee HJ; Song D; Lee SM; Kim IS; Kim H; Yang EJ; Park KH
    Lab Med; 2019 Apr; 50(2):138-144. PubMed ID: 30192966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxyhemoglobin determination in evaluating neonatal jaundice.
    Alden ER; Lynch SR; Wennberg RP
    Am J Dis Child; 1974 Feb; 127(2):214-7. PubMed ID: 4810274
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemolytic Anemia and Heart Failure Caused by Anti-C and Anti-E Immunization.
    Bilgin H; Eren A; Kara S
    J Coll Physicians Surg Pak; 2016 Jun; 26(6):539-40. PubMed ID: 27353998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.